Dataset Information

Factors influencing pharmaceutical pricing - a scoping review of academic literature in health science.

ABSTRACT:

Introduction

Pharmaceutical pricing has only recently gained space in mainstream health science literature.

Objectives

Bibliometric and content description of health science academic literature and ad hoc analysis of grey literature on factors influencing pharmaceutical pricing on databases commonly accessed by healthcare professionals.

Methods

Scoping study with no time limits performed in Medline, Scopus and Scielo, and relevant sites and databases for grey literature, using search terms with database-appropriate keywords.

Results

Two hundred four articles were published in 103 peer-reviewed journals between 1981 and 2016 (last search year). In grey literature 78 documents were retrieved in the final selection. Five key thematic clusters for analysing pharmaceutical pricing emerged: market dynamics, segmented into (i) supply-related, (ii) consumer-related and (iii) product-related; (iv) trading strategies, either buyer's or seller's and (v) regulatory approach. In peer-reviewed literature there is an overall dominance of themes referring to trading strategies and regulatory approaches and a wide thematic cluster scope. Over half of this literature was produced after the year 2010. International agency technical papers make up the most significant contributions of grey literature, with a clear focus on regulatory approaches to pricing and wider consideration of emerging countries. Research lags in the literature on factors affecting pharmaceutical pricing include impacts of financing schemes, market liberalization, internet trading and biosimilars on prices, with insufficient discussion identified for the effects of discounts/rebates, profits and price transparency.

Conclusions

Interest in pharmaceutical pricing literature is increasing. Robust evidence-producing study designs for pricing interventions will be a welcome development.

SUBMITTER: Borges Dos Santos MA

PROVIDER: S-EPMC6595602 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Factors influencing pharmaceutical pricing - a scoping review of academic literature in health science.

Borges Dos Santos Maria Angelica MA Dos Santos Dias Leticia Lucia LL Santos Pinto Cláudia Du Bocage CDB da Silva Rondineli Mendes RM Osorio-de-Castro Claudia Garcia Serpa CGS

Journal of pharmaceutical policy and practice 20190627

<h4>Introduction</h4>Pharmaceutical pricing has only recently gained space in mainstream health science literature.<h4>Objectives</h4>Bibliometric and content description of health science academic literature and ad hoc analysis of grey literature on factors influencing pharmaceutical pricing on databases commonly accessed by healthcare professionals.<h4>Methods</h4>Scoping study with no time limits performed in Medline, Scopus and Scielo, and relevant sites and databases for grey literature, us ...[more]

PMID: 31391943

Similar Datasets

Project description:ObjectiveTo describe models of academic health science centres (AHSCs) across developing countries, in order to inform AHSC development in Indonesia.DesignScoping review with systematic methods.Data sourcesOvid MEDLINE, ProQuest Central, Wiley online library, Scopus and Web of Sciences were searched for relevant publications from 1 January 2015 to 1 December 2020. 'Grey literature' was hand searched by targeted website searches, Google searches, as well as personal communication held with stakeholders in Indonesia specifically. Relevant articles regarding AHSCs in developing countries are included. The review would be synthesised to focus on the purpose, structure and core activities of AHSCs. Strategies for success were also considered.ResultsTwenty-six recognised AHSCs in developing countries were identified, located in Asia (n=13), Europe (n=1), South America (n=7) and Africa (n=5). Innovation, health system improvement and enhancement in academic capacity were the common visions. Most centres are functionally integrated and university-led. Most AHSCs include community health services to complement primary stakeholders such as academic institutions and hospitals. Limited information was identified regarding patient and public involvement and workforce capacity building. Five AHSCs have been piloted in Indonesia since 2018, integrating universities, academic hospitals and provincial health offices. However, information regarding their core activities and successes is limited.ConclusionsThe review suggests that limited published data are available on AHSC models in developing countries, but they still provide important insight into AHSC development in Indonesia. Innovation and health systems strengthening are the common visions. Functional integration with university leadership is the most common model of governance. Other than universities and hospitals, community health centres, research centres and regional health offices are common partners. There is a little description of community engagement and workforce capacity building.

Project description:Road pricing is increasingly considered as an option to support transportation infrastructure costs, manage demand, and reduce emissions. However, the extent to which implementation of such approaches may impact transportation and health equity is unclear. In this scoping review, we examine the differential transportation and health effects of road pricing policies across population groups and geographic region. We conducted a systematic database search of Transport Research International Documentation, GEOBASE, Scopus, and Ovid Medline, supplemented by bibliographic review and internet searches. Fifteen studies were included in the review. The studies evaluated area and cordon road pricing systems in Singapore, London, Stockholm, Milan, and Gothenburg, and had a median follow-up period of 12 months. Outcomes evaluated include car commuting, mode shift to public transit, accessibility to destinations, affordability, welfare, social interactions, air pollution, traffic injuries and deaths, acute asthma attacks, and life expectancy. While more studies across diverse urban contexts and policy settings will be needed to strengthen the evidence base, the existing evidence suggests road pricing has mostly net positive effects related to a reduction in car trips, air pollution, asthma attacks, and road traffic collisions, and increases in life expectancy. Frequency and ease of social interactions were found to be negatively impacted, with fewer visits to family and friends. The population groups that generally fared better across transportation and health outcomes were those with higher incomes, men, and people between the ages of 35-55. Across space, there are benefits for both the areas inside and outside the cordon boundary, but to a greater degree for the area inside. Overall, the evidence base is limited by a narrow set of health-related outcomes and a lack of longer-term studies. We did not come across any studies assessing distributional effects of noise pollution, mode shifts to walking or cycling, or other morbidities in the general population that are not listed above. In addition, there are few evaluations that include non-work trips, therefore potentially missing effects for unemployed populations or women who are more likely to make non-work trips. We find that the limited body of evidence on area and cordon pricing policies suggests these policies are beneficial for a number of transportation and health outcomes, particularly for populations inside the cordon area, but that there may be some degree of inequities in the distribution of the benefits and burdens.

Project description:BackgroundA large number of international migrants in Malaysia face challenges in obtaining good health, the extent of which is still relatively unknown. This study aims to map the existing academic literature on migrant health in Malaysia and to provide an overview of the topical coverage, quality and level of evidence of these scientific studies.MethodsA scoping review was conducted using six databases, including Econlit, Embase, Global Health, Medline, PsycINFO and Social Policy and Practice. Studies were eligible for inclusion if they were conducted in Malaysia, peer-reviewed, focused on a health dimension according to the Bay Area Regional Health Inequities Initiative (BARHII) framework, and targeted the vulnerable international migrant population. Data were extracted by using the BARHII framework and a newly developed decision tree to identify the type of study design and corresponding level of evidence. Modified Joanna Briggs Institute checklists were used to assess study quality, and a multiple-correspondence analysis (MCA) was conducted to identify associations between different variables.Results67 publications met the selection criteria and were included in the study. The majority (n=41) of studies included foreign workers. Over two-thirds (n=46) focused on disease and injury, and a similar number (n=46) had descriptive designs. The average quality of the papers was low, yet quality differed significantly among them. The MCA showed that high-quality studies were mostly qualitative designs that included refugees and focused on living conditions, while prevalence and analytical cross-sectional studies were mostly of low quality.ConclusionThis study provides an overview of the scientific literature on migrant health in Malaysia published between 1965 and 2019. In general, the quality of these studies is low, and various health dimensions have not been thoroughly researched. Therefore, researchers should address these issues to improve the evidence base to support policy-makers with high-quality evidence for decision-making.

Dataset Information

Factors influencing pharmaceutical pricing - a scoping review of academic literature in health science.

Introduction

Objectives

Methods

Results

Conclusions

Publications

Factors influencing pharmaceutical pricing - a scoping review of academic literature in health science.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets